Thema
Adalimumab
11.433
FYS6T7F842
7.190
Journal Article
6.779
Infliximab
4.581
Antibodies, Monoclonal, Humanized
3.580
Tumor Necrosis Factor-alpha
3.294
Etanercept
3.087
B72HH48FLU
3.041
Antibodies, Monoclonal
2.872
Antirheumatic Agents
2.310
OP401G7OJC
1.916
Research Support, Non-U.S. Gov't
1.905
Case Reports
1.693
Anti-Inflammatory Agents
1.669
adalimumab
1.318
Review
1.268
Immunoglobulin G
1.176
Receptors, Tumor Necrosis Factor
1.130
Methotrexate
1.123
Letter
926
YL5FZ2Y5U1
734
Multicenter Study
683
Biological Products
680
Psoriasis
617
Immunosuppressive Agents
598
Comparative Study
597
Rheumatoid Arthritis
596
Randomized Controlled Trial
543
Tumor Necrosis Factor Inhibitors
522
Ustekinumab
520
infliximab
497
Crohn’s disease
460
FU77B4U5Z0
435
Rheumatoid arthritis
434
Observational Study
425
Gastrointestinal Agents
392
golimumab
392
Dermatologic Agents
363
Certolizumab Pegol
353
Biosimilar Pharmaceuticals
328
psoriasis
317
UMD07X179E
310
91X1KLU43E
307
Systematic Review
299
Comment
292
Anti-Inflammatory Agents, Non-Steroidal
271
Biomarkers
267
Immunologic Factors
267
rheumatoid arthritis
257
Psoriatic Arthritis
246
mehr ...